title: HER2 testing, adjuvant trastuzumab use and results. Our experience in South Wales.
authors: R
authors: R
authors: Webster
authors: N
authors: N
authors: Palaniappan
authors: J
authors: J
authors: Abraham
authors: G
authors: G
authors: Bertelli
authors: B
authors: B
authors: Jasani
authors: P
authors: P
authors: Barrett-Lee
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000201:enzymology*; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*; D000068878:Trastuzumab; D014852:Wales
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab